Nigeria National Oral PrEP Implementation Plan (2022-24) Assessment Presentation

18 June 2024

From October 2023 to April 2024, MOSAIC supported the Federal Ministry of Health to evaluate the National Oral PrEP Implementation Plan (Jan 2022 – Jan 2024). The purpose of the evaluation was to assess the achievement of priority activities stipulated in the National Oral PrEP Implementation Plan (Jan 2022-Jan 2024) against the intended objectives. The findings of the assessment will inform the development of the next iteration of the national PrEP Implementation Plan which will include CAB PrEP.

Featured Resources

Document

Pre-Exposure Prophylaxis and Adolescent Girls and Young Women in Eastern and Southern Africa: The latest insights

Eastern and southern Africa (ESA) is the world’s most heavily HIV-impacted region, with adolescent girls and young women (AGYW) disproportionately affected. To support the scale-up of PrEP amongst AGYW in ESA, in September 2021 UNICEF and partners released the implementation brief “Improving the Quality of Pre-Exposure Prophylaxis Implementation for Adolescent Girls and Young Women in…

External Link

WHO Implementation Tool for Pre-Exposure Prophylaxis (PrEP) of HIV Infection

The WHO has developed this series of modules to support the implementation of PrEP among a range of populations in different settings.

External Link

Low Selection of HIV PrEP Refills at Private Pharmacies among Clients who Initiated PrEP at Public Clinics: Findings from a mixed-methods study in Kenya

This article from BMC Health Services Research describes the impact of a pilot project to permit oral PrEP users to obtain refills at private pharmacies for an additional fee.

Document

Nigeria National Oral PrEP Implementation Plan (2022-24) Assessment Report

External Link

Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled analysis from 72 global studies

This article from Clinical Infectious Diseases reviews 72 prospective studies of daily oral PrEP (TDF/FTC) to evaluate its impact on HIV-1 incidence, drug resistance, adherence, and bone and renal safety in diverse settings.

Document

MOSAIC (Maximizing Options to Advance Informed Choice for HIV Prevention)

Short introduction to MOSAIC, a project working across multiple countries to implement user-centered research and research translation efforts to identify, understand, and remove barriers to new product introduction, access, and use; coordinate and provide technical assistance to global, national, and subnational stakeholders to expedite product launch and scale-up; and strengthen the capacity of a wide…

Document

Access, Adherence, and Acute HIV Infections: A characterization of seroconversion with PrEP in Eswatini

This poster, presented at the INTEREST conference in Cotonou, Benin in 2024, outlines characteristics of seroconversions by women using oral PrEP or the dapivirine vaginal ring in Eswatini.

External Link

Youth-friendly Services Was the Magic: Experiences of adolescent girls and young women in the community PrEP study, South Africa

This article from Global Public Health describes the results of a study to measure the impact of HIV prevention empowerment counselling on PrEP use by adolescent girls and young women in South Africa.

External Link

Discontinuation of HIV Oral Pre-exposure Prophylaxis: Findings from programmatic surveillance within two general population HIV programs in Nigeria

This article from BMC Public Health explores the factors associated with discontinuation of oral PrEP within one month of initiation in two large HIV projects in Nigeria.

External Link

Lessons Learnt from Daily Oral PrEP Delivery to Inform National Planning for PrEP Ring Introduction for Women in Low-income and Middle-income Countries: A qualitative inquiry of international stakeholders

This article from BMJ Global Health synthesises lessons learnt from oral PrEP, based on discussions with international stakeholders, to inform the development of a costed rollout plan template for longer acting PrEP methods, including the dapivirine vaginal ring.